Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

SELL
$60.95 - $75.51 $17.5 Million - $21.7 Million
-287,866 Reduced 96.27%
11,151 $694,000
Q4 2022

Feb 23, 2023

SELL
$67.18 - $84.11 $880,461 - $1.1 Million
-13,106 Reduced 4.2%
299,017 $24 Million
Q4 2022

Feb 17, 2023

SELL
$67.18 - $84.11 $880,461 - $1.1 Million
-13,106 Reduced 4.2%
299,017 $24 Million
Q3 2022

Feb 23, 2023

BUY
$66.18 - $82.86 $867,355 - $1.09 Million
13,106 Added 4.38%
312,123 $20.8 Million
Q3 2022

Nov 17, 2022

SELL
$66.18 - $82.86 $480,400 - $601,480
-7,259 Reduced 2.27%
312,123 $20.8 Million
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $21.1 Million - $25.5 Million
319,382 New
319,382 $25.4 Million
Q4 2021

Feb 15, 2022

SELL
$63.34 - $74.11 $19.3 Million - $22.6 Million
-304,684 Closed
0 $0
Q3 2021

Nov 18, 2021

SELL
$68.67 - $84.02 $203,125 - $248,531
-2,958 Reduced 0.96%
304,684 $21 Million
Q1 2021

May 14, 2021

BUY
$76.02 - $100.5 $660,993 - $873,847
8,695 Added 2.91%
307,642 $25 Million
Q4 2020

Feb 19, 2021

BUY
$80.74 - $97.7 $2.48 Million - $3 Million
30,692 Added 11.44%
298,947 $26 Million
Q2 2020

Aug 11, 2020

SELL
$74.18 - $108.93 $1.56 Million - $2.29 Million
-20,995 Reduced 7.26%
268,255 $27.9 Million
Q4 2019

Feb 21, 2020

BUY
$73.04 - $95.72 $1.7 Million - $2.23 Million
23,337 Added 8.78%
289,250 $25.3 Million
Q3 2019

Nov 15, 2019

BUY
$72.82 - $86.52 $989,259 - $1.18 Million
13,585 Added 5.38%
265,913 $19.7 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $1.52 Million - $1.84 Million
20,691 Added 8.93%
252,328 $21.4 Million
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $607,188 - $842,288
9,553 Added 4.3%
231,637 $19.9 Million
Q4 2018

Feb 15, 2019

BUY
$58.5 - $69.94 $582,660 - $696,602
9,960 Added 4.7%
222,084 $18.5 Million
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $1.22 Million - $1.68 Million
19,992 Added 10.41%
212,124 $13.9 Million
Q1 2018

Apr 13, 2018

BUY
$83.06 - $100.98 $1.11 Million - $1.35 Million
13,374 Added 7.48%
192,132 $16 Million
Q4 2017

Jan 17, 2018

BUY
$93.56 - $116.6 $1.93 Million - $2.41 Million
20,633 Added 13.05%
178,758 $16.9 Million
Q3 2017

Oct 16, 2017

BUY
$109.15 - $138.27 $17.3 Million - $21.9 Million
158,125
158,125 $17.9 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.